Ragweed pollen starts climbing in late August and peaks in September, which is why the shelf goes up in the pharmacy around now. AccuWeather's 2026 outlook expects an intense weed-pollen season, heaviest across the Rockies.
So here is a narrower question than "what works": what has the government's own evidence review actually looked at? The National Center for Complementary and Integrative Health, part of NIH, keeps a digest of the science for this exact season. Reading it next to a pharmacy shelf is instructive, because they are not stocking the same list.
What the digest discusses
Butterbur has the most supportive language of anything in it. NCCIH reports that butterbur is "superior to placebo or similarly effective compared with nonsedative antihistamines." That is a strong sentence by the standards of this field, and it arrives with an immediate qualifier that has to travel with it: "firm conclusions could not be drawn because three of the large trials reviewed received financial support from a manufacturer."
The safety half is not a footnote. Butterbur contains pyrrolizidine alkaloids, which NCCIH links to liver damage, lung damage and possible cancer, so only products processed to remove them should be considered at all. And even that is not a clean rule: NCCIH notes that some products sold as PA-free have still been associated with liver damage, naming Petadolex. It is not considered safe in pregnancy or breastfeeding. We do not score butterbur, and this is why: the efficacy signal is real enough to mention and the per-product safety question is not one we can answer for you from a label.
Probiotics get a split verdict. NCCIH says the "current evidence is not sufficiently strong to verify a preventive role," while noting they "may improve the overall quality of life and nasal symptom scores." Its conclusion is that routine use "cannot be recommended." Our own probiotic scoring is strain-specific for the same reason the digest hedges: the category is not one thing.
Honey is the clearest negative in the document. "There is no convincing scientific evidence that honey relieves seasonal allergies." One pilot study exists and NCCIH labels its findings preliminary. Local honey is the most durable folk remedy in this area and it is the one with the least behind it.
Saline nasal irrigation is the quiet winner, and it is not a supplement. NCCIH reports that regular use "over a period of up to 7 weeks was observed to have beneficial effects." It costs a few dollars. The one real caution is the water: use distilled, sterile or previously boiled water rather than straight tap, because NCCIH ties tap water to a risk of Naegleria fowleri infection.
What the digest does not discuss
Quercetin, stinging nettle and bromelain are the three ingredients most often sold as a seasonal stack. None of them appears in that digest.
Be careful what you take from that. An absence from one agency review is not a finding that no evidence exists; it is a fact about that document. What it does tell you is that these are not among the approaches the agency thought worth summarising for clinicians on this topic, which is a meaningful signal about how developed the human evidence is.
Our own scoring lands in a compatible place without needing the digest. Quercetin earns its place on this site for two things, and seasonal symptoms is not either of them: modest blood-pressure reduction at absorbable doses, and reduced upper-respiratory infection rates in people under heavy physical stress. Our profile's own guidance for anyone considering it for the season is to keep expectations modest and treat it as something to try alongside, not instead of, whatever already works. Absorption is the other catch: plain quercetin is poorly absorbed, so the form on the label matters more than the milligram count.
Stinging nettle and bromelain are frequently bundled into the same capsule as quercetin. Bundling is a formulation decision, not evidence.
The honest read
Of everything in the federal digest for this season, the approach with supportive language and no product-quality asterisk is a saline rinse, which is not a supplement and costs less than any of them. The ingredient with the best trial record is one we do not sell and would not, on safety grounds we cannot verify per bottle. And the three ingredients the aisle actually stocks for this are absent from the review entirely.
That is not an argument that nothing helps. Antihistamines exist, they are cheap, and they are studied. It is an argument about where to spend first, and about being clear-eyed that the seasonal supplement shelf is built more on plausible mechanism than on trials.
None of this is medical advice, and none of these products treat or prevent any condition. If your symptoms are severe, disrupt sleep, or are new, that is a conversation for a clinician rather than a shelf.